Acromegaly and cancer risk: A cohort study in Sweden and Denmark

Cancer Causes and Control

Volumn 13, Issue 5, 2002, Pages 395-400

  Baris, D ^a   Gridley, G ^a   Ron, E ^a   Weiderpass, E ^b,c   Mellemkjaer, L ^d   Ekbom, A ^b,c   Olsen, J H ^d   Baron, J A ^e   Fraumeni Jr, J F ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

^b KAROLINSKA INSTITUTE   (Sweden)

^c INTERNATIONAL AGENCY FOR RESEARCH ON CANCER   (France)

^d DANISH CANCER SOCIETY RESEARCH CENTER   (Denmark)

^e DARTMOUTH MEDICAL SCHOOL   (United States)

Author keywords

Acromegaly; Cancer; Cohort

Indexed keywords

SOMATOMEDIN C; GROWTH PROMOTOR; RECOMBINANT SOMATOMEDIN C; SIGNAL PEPTIDE;

ACROMEGALY; APOPTOSIS; ARTICLE; BONE CANCER; BRAIN CANCER; CANCER; CANCER EPIDEMIOLOGY; CANCER INCIDENCE; CANCER RADIOTHERAPY; CANCER RISK; CELL PROLIFERATION; COHORT ANALYSIS; COLON CANCER; CONTROLLED STUDY; DENMARK; FOLLOW UP; HORMONE BLOOD LEVEL; HUMAN; KIDNEY CANCER; MAJOR CLINICAL STUDY; POPULATION RESEARCH; PRIORITY JOURNAL; RECTUM CANCER; REGISTER; RISK ASSESSMENT; SMALL INTESTINE CANCER; SWEDEN; THYROID CANCER; BLOOD; BRAIN TUMOR; FEMALE; INCIDENCE; MALE; MIDDLE AGED; NEOPLASM; RISK FACTOR; STATISTICS; THYROID TUMOR;

ACROMEGALY; BRAIN NEOPLASMS; COHORT STUDIES; DENMARK; FEMALE; GROWTH SUBSTANCES; HUMAN; INCIDENCE; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; MALE; MIDDLE AGE; NEOPLASMS; REGISTRIES; RISK FACTORS; SWEDEN; THYROID NEOPLASMS; HUMANS; MIDDLE AGED;

EID: 0035987679     PISSN: 09575243     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1015713732717     Document Type: Article

References (50)

1. Acromegaly
2. The prevalence of colonic polyps in acromegaly: A colonoscopic and pathological study in 103 patients
3. High prevalence of colonic polyps in patients with acromegaly. Influence of sex and age
4. Colon cancer and polyps in acromegaly: Increased risk associated with family history of colon cancer
5. Clinical review 18: Are patients with acromegaly at increased risk for neoplasia?
6. Mortality and cancer incidence in acromegaly: A retrospective cohort study
7. Gastrointestinal tumors in acromegalic patients
8. Increased incidence of neoplasia in patients with pituitary adenomas
9. Acromegaly and gastrointestinal cancer
10. Clinical perspective: Acromegaly and cancer: A problem
11. IGF-I and IGF-II in relation to colorectal cancer
12. Prospective study of colorectal cancer risk in men and plasma levels of insulin-like growth factor (IGF)-I and IGF-binding protein-3
13. A prospective study of plasma insulin-like growth factor-1 and binding protein-3 and risk of colorectal neoplasia in women
14. Plasma insulin-like growth factor-I and prostate cancer risk: A prospective study
15. Insulin-like growth factor-I in relation to premenopausal ductal carcinoma in situ of the breast
16. Primary liver cancer, other malignancies, and mortality risks following porphyria: A cohort study in Denmark and Sweden
17. Risk of second brain tumour after conservative surgery and radiotherapy for pituitary adenoma
18. An association between acromegaly and thyroid carcinoma
19. Increased incidence of neoplasia in females with acromegaly
20. Insulin-like growth factor-I: A key regulator of human cancer risk?
21. Increased epithelial cell proliferation in the colon of patients with acromegaly
22. Mutations of the MEN1 tumor suppressor gene in pituitary tumors
23. Acromegaly from ectopic growth hormone-releasing hormone secretion by a malignant carcinoid tumor: Successful treatment with long-acting somatostatin analogue SMS 201-995
24. Goiter associated with acromegaly: Sonographic and scintigraphic findings of the thyroid gland
25. Increased incidence of euthyroid and hyperthyroid goiters independently of thyrotropin in patients with acromegaly
26. Review of thyroid cancer cases among patients with previous benign thyroid disorders
27. A pooled analysis of case-control studies of thyroid cancer. IV. Benign thyroid diseases
28. Insulin-like growth factor-I stimulates the growth of rat thyroid cells in culture and synergizes the stimulation of DNA synthesis induced by TSH and Graves'-IgG
29. Clinical genetics of multiple endocrine neoplasias, Carney complex and related syndromes
30. Head and neck radiation carcinogenesis: Epidemiologic evidence
31. Glioma arising after radiation therapy for pituitary adenoma. A report of four patients and estimation of risk
32. Neoplasms of the nervous system
33. Tumors of the brain and nervous system after radiotherapy in childhood
34. Coexistence of growth hormone-secreting pituitary adenoma and intracranial meningioma: A case report and review of the literature
35. Insulin- and insulin-like growth-factor-I receptor tyrosine-kinase activities in human renal carcinoma
36. Acromegaly and cardiovascular disorders. A prospective study
37. Hypertension, obesity and their medications in relation to renal cell carcinoma
38. Obesity, hypertension, and the risk of kidney cancer in men
39. Association of acromegaly and chondrosarcoma
40. Osteosarcoma associated with acromegaly: A case report
41. Effects of recombinant human insulin-like growth factor I and II (IGF-I/-II) and growth hormone (GH) on the growth of normal adult human osteoblast-like cells and human osteogenic sarcoma cells
42. Fibrous dysplasia of the skull with acromegaly and sarcomatous transformation: Two cases with a review of the literature
43. Acromegaly
44. Circulating concentrations of insulin-like growth factor-I and risk of breast cancer
45. Insulin-like growth factor 1 in relation to prostate cancer and benign prostatic hyperplasia
46. Insulin-like growth factor 1 and prostate cancer risk: A population-based, case-control study
47. Joint effect of insulin-like growth factors and mutagen sensitivity in lung cancer risk
48. A prospective study of insulin-like growth factor-I, IGF-binding proteins-1, -2 and -3 and lung cancer risk in women
49. Acromegaly and multiple myeloma